Canopy Growth Corp (NASDAQ:CGC)
| 0.8265 Delayed Data As of 3:59pm ET |  -0.0085 / -1.02%Today’s Change | 0.80 Today|||52-Week Range 5.10 | -64.22% Year-to-Date |
| SECTOR Process Industries | INDUSTRY Agricultural Commodities/Milling | MARKET CAP $449.7M |
Company Description
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Contact Information
Canopy Growth Corp. 1 Hershey Drive Smith Falls Ontario K7A 0A8 |
Employees
Shareholders
| Mutual fund holders | -- |
| Individual stakeholders | -- |
| Other institutional | -- |
Top Executives
| David Eric Klein | Chief Executive Officer & Non-Independent Director |
| Jonathan Di Tosto | Chief Operating Officer |
| Judy Hong | Chief Financial Officer & VP-Investor Relations |
| Mark A. Ware | Chief Medical Officer |
| Thomas Stewart | Chief Accounting Officer & Vice President |
